DUBLIN, Feb. 12, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/jcl34v/genomics_market) has announced the addition of the "Genomics Market by Products and Services - Global Forecast to 2018" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The global market was valued at $11.11 billion in 2013 and is expected to grow at a CAGR of more than 10.0% during the forecast period. The global genomics products market is segmented by products, technologies, and applications. The product segmentation includes instruments, consumables, and services. The global market was categorized into nucleic acid extraction and purification, PCR, DNA sequencing and DNA microarray on the basis of technology. Diagnostics, academic research, drug discovery, agriculture and animal research, and personalized medicine represented the key areas of the global genomics application segmentation.

The global genomics instrument and consumables segments were further categorized into nucleic acid extraction and purification systems, PCR, DNA microarrays, DNA sequencers, and NGS platforms. The Consumables segment of the global market held the maximum share among all other product segments.

The major drivers of the global market are extensive government funding in gene-related researches and increase in demand for clinical application such as personalized medicine. Technological innovations, and low cost and time associated with DNA-sequencing are also expected to influence the market growth during the forecast period; however, decreasing average selling prices of genomics instruments and services, and increased market consolidation are anticipated to challenge the market growth.

Market study on different genomics technologies identified silica-based nucleic acid extraction and purification, RT-PCR, oligonucleotide microarrays, and next generation sequencing as major technological breakthroughs in the global market. Of the various application segments, the diagnostics segment was found to contribute the largest share of revenues to the global genomics applications market, followed by drug discovery.

In 2013, North America was found to be the regional market that contributed the largest share of revenues to the global market, followed by Europe, APAC, and RoW. The market in the APAC region is expected to grow at the highest CAGR during the forecast period, due to increasing demand for diagnostics and academic research applications. Notable players in the market include Roche Diagnostic (Switzerland), Life Technologies, Corp. (U.S.), QIAGEN (Netherlands), Illumina, Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.). Roche, Life Technologies, and QIAGEN were the top three market players that accounted for over 40% of the revenues earned by the global market in 2013.

Key Topics Covered:

1 Introduction

2 Executive Overview

3 Total Global Genomics Market

4 Global Genomics Market, By Product Segment

5 Global Genomics Market, By Technology

6 Global Genomics Market, By Application

7 Global Genomics Market, By Geography

8 Mergers And Acquisitions

9 Competitive Strategies

10 Company Profiles

11 Appendix

Companies Mentioned:

• Affymetrix, Inc.
• Agilent Technologies, Inc.
• Bgi
• Bio-Rad Laboratories, Inc.
• Cepheid
• Ge Healthcare
• Illumina, Inc.
• Life Technologies, Corp.
• Qiagen
• Roche Diagnostics

For more information visit http://www.researchandmarkets.com/research/jcl34v/genomics_market

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets